Does the Success of Work-related Interventions in the Rehabilitation of Neurological Diseases Depend on the Return-to-Work Prognosis? A Re-analysis of 2 Randomised Controlled Trials

Die Rehabilitation
M Streibelt, A Menzel-Begemann

Abstract

The paper examines whether patients with neurological diseases and a poor return to work (RTW) prognosis gain more from work-related medical rehabilitation (WMR). Re-analysis of matched samples of 2 randomised controlled trials (N=442; questionnaire at admission of rehabilitation and 15-month follow-up). Linear regression models were used calculating the effect of the WMR dependent on the RTW prognosis. Primary outcome was time of sick leave in the follow-up and physical and mental health measured by the SF-36. As secondary outcomes, strategies of coping skills and work-related attitudes were defined. Only for patients with a high non-RTW risk could positive effects of WMR be demonstrated on mental health, coping skills and the scale "work as a resource". In the 15-month follow-up, there were no differences in effects on duration of sick leave and physical health. The results based on this analysis indicate that patients with neurological diseases derive benefit from WMR only if their empirical RTW prognosis is poor. However, this only applies for the mental health in the medium term. Our study confirms the previous findings that suggest different effectiveness of the WMR for patients with different RTW risk.

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.